Matches in Nanopublications for { ?s ?p "[For smoking HBV carriers, the odds ratios of developing HCC for those heterozygous and homozygous for the NAT2*4 functional allele compared with those without any copies of the functional allele (reference group) were 2.67 (95% confidence interval 1.15-6.22) and 2.58 (95% confidence interval 1.04-6.43), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- assertion description "[For smoking HBV carriers, the odds ratios of developing HCC for those heterozygous and homozygous for the NAT2*4 functional allele compared with those without any copies of the functional allele (reference group) were 2.67 (95% confidence interval 1.15-6.22) and 2.58 (95% confidence interval 1.04-6.43), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[For smoking HBV carriers, the odds ratios of developing HCC for those heterozygous and homozygous for the NAT2*4 functional allele compared with those without any copies of the functional allele (reference group) were 2.67 (95% confidence interval 1.15-6.22) and 2.58 (95% confidence interval 1.04-6.43), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP90810.RAYv071Q2KEfPv27dmj1PTfAnR0giGyctAN9tMuu-VxLY130_assertion description "[For smoking HBV carriers, the odds ratios of developing HCC for those heterozygous and homozygous for the NAT2*4 functional allele compared with those without any copies of the functional allele (reference group) were 2.67 (95% confidence interval 1.15-6.22) and 2.58 (95% confidence interval 1.04-6.43), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90810.RAYv071Q2KEfPv27dmj1PTfAnR0giGyctAN9tMuu-VxLY130_provenance.
- NP944570.RADXZvH_cFllBZjfeHqahqUrDZu6mMcCULIybH2A0HnYM130_assertion description "[For smoking HBV carriers, the odds ratios of developing HCC for those heterozygous and homozygous for the NAT2*4 functional allele compared with those without any copies of the functional allele (reference group) were 2.67 (95% confidence interval 1.15-6.22) and 2.58 (95% confidence interval 1.04-6.43), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP944570.RADXZvH_cFllBZjfeHqahqUrDZu6mMcCULIybH2A0HnYM130_provenance.
- NP823166.RA8YhVxpTVMtEGvlocFlREsGDd9eaBhz4QOfIhUO1_OzA130_assertion description "[For smoking HBV carriers, the odds ratios of developing HCC for those heterozygous and homozygous for the NAT2*4 functional allele compared with those without any copies of the functional allele (reference group) were 2.67 (95% confidence interval 1.15-6.22) and 2.58 (95% confidence interval 1.04-6.43), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP823166.RA8YhVxpTVMtEGvlocFlREsGDd9eaBhz4QOfIhUO1_OzA130_provenance.
- NP951377.RA2iKzN8ZulRQ35VekdMq73WusWrRFN-T-fZcfQZ4nPKQ130_assertion description "[For smoking HBV carriers, the odds ratios of developing HCC for those heterozygous and homozygous for the NAT2*4 functional allele compared with those without any copies of the functional allele (reference group) were 2.67 (95% confidence interval 1.15-6.22) and 2.58 (95% confidence interval 1.04-6.43), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP951377.RA2iKzN8ZulRQ35VekdMq73WusWrRFN-T-fZcfQZ4nPKQ130_provenance.
- NP297747.RAy4DNUu1mbkXmbYpD3kGl4_C7C8zb5nQl3XNZDc52iqg130_assertion description "[For smoking HBV carriers, the odds ratios of developing HCC for those heterozygous and homozygous for the NAT2*4 functional allele compared with those without any copies of the functional allele (reference group) were 2.67 (95% confidence interval 1.15-6.22) and 2.58 (95% confidence interval 1.04-6.43), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP297747.RAy4DNUu1mbkXmbYpD3kGl4_C7C8zb5nQl3XNZDc52iqg130_provenance.
- NP297749.RAwBtyVzcn5bzyDXzO5G_i0EhIjxDeMrQtSJBL-dCgaPo130_assertion description "[For smoking HBV carriers, the odds ratios of developing HCC for those heterozygous and homozygous for the NAT2*4 functional allele compared with those without any copies of the functional allele (reference group) were 2.67 (95% confidence interval 1.15-6.22) and 2.58 (95% confidence interval 1.04-6.43), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP297749.RAwBtyVzcn5bzyDXzO5G_i0EhIjxDeMrQtSJBL-dCgaPo130_provenance.
- NP217783.RAkjltaKyU5u7gPNO1WasZ6pLc_UF-eY9TI9yraUB6Tuo130_assertion description "[For smoking HBV carriers, the odds ratios of developing HCC for those heterozygous and homozygous for the NAT2*4 functional allele compared with those without any copies of the functional allele (reference group) were 2.67 (95% confidence interval 1.15-6.22) and 2.58 (95% confidence interval 1.04-6.43), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217783.RAkjltaKyU5u7gPNO1WasZ6pLc_UF-eY9TI9yraUB6Tuo130_provenance.
- NP68099.RAO9jfRRMxuR3KkuiEaz250BnZTMFlE3SW0fd6om28ahc130_assertion description "[For smoking HBV carriers, the odds ratios of developing HCC for those heterozygous and homozygous for the NAT2*4 functional allele compared with those without any copies of the functional allele (reference group) were 2.67 (95% confidence interval 1.15-6.22) and 2.58 (95% confidence interval 1.04-6.43), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP68099.RAO9jfRRMxuR3KkuiEaz250BnZTMFlE3SW0fd6om28ahc130_provenance.
- NP297743.RAuN6-lEq4a2Uaj8vyb9Tg96YQGJm3IV44YKWd0IqCxsU130_assertion description "[For smoking HBV carriers, the odds ratios of developing HCC for those heterozygous and homozygous for the NAT2*4 functional allele compared with those without any copies of the functional allele (reference group) were 2.67 (95% confidence interval 1.15-6.22) and 2.58 (95% confidence interval 1.04-6.43), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP297743.RAuN6-lEq4a2Uaj8vyb9Tg96YQGJm3IV44YKWd0IqCxsU130_provenance.